enVVeno Medical (NVNO) Accumulated Depreciation (2017 - 2025)

enVVeno Medical's Accumulated Depreciation history runs 9 years deep, the most recent figure standing at $1.4 million for Q4 2025.

• In Q4 2025, Accumulated Depreciation rose 10.82% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (up 10.82% YoY), while the FY2025 annual figure was $1.4 million, up 10.82% from the prior year.
• Accumulated Depreciation was $1.4 million for Q4 2025 at enVVeno Medical, up from $1.3 million in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $1.4 million in Q4 2025 to a low of $515521.0 in Q1 2021.
• Historically, Accumulated Depreciation has averaged $938505.4 across 5 years, with a median of $903000.0 in 2023.
• The sharpest annual moves came in 2022 and 2025: Accumulated Depreciation jumped 33.46% in 2022, then increased 10.82% in 2025.
• A 5-year view of Accumulated Depreciation shows it stood at $637000.0 in 2021, then surged by 33.28% to $849000.0 in 2022, then increased by 25.91% to $1.1 million in 2023, then rose by 17.59% to $1.3 million in 2024, then advanced by 10.82% to $1.4 million in 2025.
• The last three Accumulated Depreciation figures came in at $1.4 million (Q4 2025), $1.3 million (Q1 2025), and $1.3 million (Q4 2024), per Business Quant data.